FAIRFIELD, BUSH & CO. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
FAIRFIELD, BUSH & CO. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,395,576
-17.6%
33,336
-18.4%
2.22%
+95.5%
Q2 2023$4,120,732
+8.7%
40,836
-0.9%
1.14%
-15.0%
Q1 2023$3,791,386
+23.8%
41,211
+22.1%
1.34%
-33.9%
Q4 2022$3,061,807
+18.3%
33,750
-0.9%
2.02%
+10.6%
Q3 2022$2,588,000
-17.6%
34,042
-8.4%
1.83%
-1.0%
Q2 2022$3,140,000
-14.0%
37,145
-10.8%
1.85%
+0.8%
Q1 2022$3,652,000
+0.4%
41,623
+0.1%
1.83%
+4.7%
Q4 2021$3,636,000
-16.2%
41,565
-21.7%
1.75%
+24.0%
Q3 2021$4,341,000
-23.1%
53,090
-14.2%
1.41%
-8.1%
Q2 2021$5,647,000
+1.6%
61,894
-4.8%
1.54%
-3.2%
Q1 2021$5,556,000
-10.3%
65,003
-0.9%
1.59%
-12.2%
Q4 2020$6,196,000
+8.6%
65,6130.0%1.81%
-0.8%
Q3 2020$5,706,000
-0.5%
65,613
-0.1%
1.82%
-10.9%
Q2 2020$5,734,000
+5.8%
65,653
-0.1%
2.05%
-9.2%
Q1 2020$5,420,000
-15.1%
65,732
-2.5%
2.25%
-4.1%
Q4 2019$6,384,000
+7.8%
67,420
-1.0%
2.35%
+14.9%
Q3 2019$5,920,000
-8.8%
68,119
-4.2%
2.05%
-7.5%
Q2 2019$6,490,000
-13.6%
71,081
-9.0%
2.21%
-11.3%
Q1 2019$7,514,000
+10.6%
78,153
-1.2%
2.49%
+6.8%
Q4 2018$6,791,000
-1.0%
79,141
-0.6%
2.34%
+21.3%
Q3 2018$6,861,000
+3.2%
79,636
-9.5%
1.93%
-1.4%
Q2 2018$6,647,000
-11.1%
87,989
-4.9%
1.95%
-10.0%
Q1 2018$7,477,000
-10.7%
92,486
-7.2%
2.17%
-5.9%
Q4 2017$8,370,000
+2.9%
99,693
+5.2%
2.31%
-9.2%
Q3 2017$8,137,000
-48.6%
94,777
-50.0%
2.54%
+0.2%
Q2 2017$15,828,000
+125.0%
189,624
+100.2%
2.54%
+15.7%
Q1 2017$7,034,000
+1.0%
94,702
-0.9%
2.19%
-3.1%
Q4 2016$6,962,000
-9.7%
95,577
-2.1%
2.26%
-9.4%
Q3 2016$7,709,000
-5.2%
97,627
-1.0%
2.50%
-11.5%
Q2 2016$8,135,000
+11.8%
98,596
-1.8%
2.82%
+8.5%
Q1 2016$7,276,000
+76.1%
100,439
+109.2%
2.60%
+80.0%
Q4 2015$4,131,000
+3.6%
48,014
+10.7%
1.44%
-17.5%
Q3 2015$3,988,000
-33.1%
43,389
-28.4%
1.75%
-2.2%
Q2 2015$5,959,000
-0.8%
60,592
-0.5%
1.79%
+2.3%
Q1 2015$6,005,000
+5.0%
60,898
-1.3%
1.75%
+6.9%
Q4 2014$5,717,000
-2.2%
61,703
-0.6%
1.64%
-2.4%
Q3 2014$5,843,000
+2.5%
62,078
-1.4%
1.68%
+0.4%
Q2 2014$5,698,000
+14.3%
62,937
+7.3%
1.67%
-28.8%
Q1 2014$4,987,000
+5.7%
58,662
-0.0%
2.35%
+11.4%
Q4 2013$4,717,000
-53.7%
58,687
-55.8%
2.11%
+36.9%
Q3 2013$10,183,000
-98.2%
132,760
+744.0%
1.54%
+442.3%
Q2 2013$556,690,00015,7300.28%
Other shareholders
NOVARTIS A G shareholders Q1 2023
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders